| Year |
Citation |
Score |
| 2023 |
Chen W, Lin C, Su F, Fang Y, Liu G, Chen YC, Zhou X, Yao X, Ashford CB, Li F, Ashford JW, Fu Q, Pei Z. Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers. Journal of Alzheimer's Disease : Jad. PMID 37355900 DOI: 10.3233/JAD-230182 |
0.329 |
|
| 2022 |
Ashford JW, Schmitt FA, Bergeron MF, Bayley PJ, Clifford JO, Xu Q, Liu X, Zhou X, Kumar V, Buschke H, Dean M, Finkel SI, Hyer L, Perry G. Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. Journal of Alzheimer's Disease : Jad. PMID 35431257 DOI: 10.3233/JAD-220211 |
0.349 |
|
| 2020 |
Bergeron MF, Landset S, Zhou X, Ding T, Khoshgoftaar TM, Zhao F, Du B, Chen X, Wang X, Zhong L, Liu X, Ashford JW. Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 32894241 DOI: 10.3233/Jad-191340 |
0.349 |
|
| 2020 |
Ashford JW. Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology. 94: 593-594. PMID 32229635 DOI: 10.1212/Wnl.0000000000009184 |
0.345 |
|
| 2019 |
Zhou X, Ashford JW. Advances in screening instruments for Alzheimer's disease. Aging Medicine (Milton (N.S.W)). 2: 88-93. PMID 31942517 DOI: 10.1002/agm2.12069 |
0.337 |
|
| 2019 |
Taylor JL, Hambro BC, Strossman ND, Bhatt P, Hernandez B, Ashford JW, Cheng JJ, Iv M, Adamson MM, Lazzeroni LC, McNerney MW. The effects of repetitive transcranial magnetic stimulation in older adults with mild cognitive impairment: a protocol for a randomized, controlled three-arm trial. Bmc Neurology. 19: 326. PMID 31842821 DOI: 10.1186/S12883-019-1552-7 |
0.398 |
|
| 2019 |
Bergeron MF, Landset S, Tarpin-Bernard F, Ashford CB, Khoshgoftaar TM, Ashford JW. Episodic-Memory Performance in Machine Learning Modeling for Predicting Cognitive Health Status Classification. Journal of Alzheimer's Disease : Jad. PMID 31177223 DOI: 10.3233/Jad-190165 |
0.375 |
|
| 2019 |
Ashford JW, Tarpin-Bernard F, Ashford CB, Ashford MT. A Computerized Continuous-Recognition Task for Measurement of Episodic Memory. Journal of Alzheimer's Disease. 69: 385-399. PMID 30958384 DOI: 10.3233/Jad-190167 |
0.377 |
|
| 2019 |
Ashford JW. The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau. Journal of Alzheimer's Disease. 68: 77-83. PMID 30814359 DOI: 10.3233/Jad-181198 |
0.409 |
|
| 2019 |
Smith CJ, Ashford JW, Perfetti TA. Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress. Journal of Alzheimer's Disease : Jad. PMID 30814349 DOI: 10.3233/Jad-181089 |
0.373 |
|
| 2019 |
Hoek MDvd, Nieuwenhuizen A, Keijer J, Ashford JW. The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment Journal of Alzheimer's Disease. 67: 1045-1054. PMID 30776011 DOI: 10.3233/Jad-181003 |
0.343 |
|
| 2019 |
Weiner MW, Nosheny RL, Mackin RS, Truran-Sacrey D, Flenniken D, Camacho MR, Kwang W, Howell T, Fockler J, Alosco ML, Stern RA, Montine TJ, Cholerton B, Ashford JW, Maruff P, et al. S4-01-01: IDENTIFYING ELDERS AT RISK FOR COGNITIVE DECLINE USING THE BRAIN HEALTH REGISTRY (BHR) Alzheimer's & Dementia. 15: P1215-P1215. DOI: 10.1016/J.Jalz.2019.06.4709 |
0.323 |
|
| 2016 |
Sun W, Lee S, Huang X, Liu S, Inayathullah M, Kim KM, Tang H, Ashford JW, Rajadas J. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment. Scientific Reports. 6: 34784. PMID 27708431 DOI: 10.1038/Srep34784 |
0.362 |
|
| 2015 |
Salehi A, Ashford JW, Mufson EJ. Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective. Current Alzheimer Research. PMID 26487155 DOI: 10.2174/1567205012999151021102914 |
0.337 |
|
| 2015 |
Ashford JW. Treatment of Alzheimer’s Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future Directions Journal of Alzheimer's Disease. 47: 149-156. PMID 26402763 DOI: 10.3233/Jad-150381 |
0.402 |
|
| 2015 |
Ashford JW, Mahoney L, Burkett T. A Role for Complementary and Integrative Medicine in Alzheimer's Disease Prevention. Journal of Alzheimer's Disease : Jad. 48: 13-4. PMID 26401924 DOI: 10.3233/Jad-150505 |
0.375 |
|
| 2014 |
Taylor JL, Scanlon BK, Farrell M, Hernandez B, Adamson MM, Ashford JW, Noda A, Murphy GM, Weiner MW. APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years. Neurobiology of Aging. 35: 2479-85. PMID 24929969 DOI: 10.1016/J.Neurobiolaging.2014.05.011 |
0.391 |
|
| 2014 |
Ashford JW, Furst AJ. Advancing brain imaging for Alzheimer's disease: integrating anatomic and physiologic measures. Journal of Alzheimer's Disease : Jad. 41: 759-63. PMID 24840569 DOI: 10.3233/Jad-141100 |
0.352 |
|
| 2014 |
Johnston JM, Hu WT, Fardo DW, Greco SJ, Perry G, Montine TJ, Trojanowski JQ, Shaw LM, Ashford JW, Tezapsidis N. Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. Current Alzheimer Research. 11: 165-74. PMID 24359504 DOI: 10.2174/1567205010666131212114156 |
0.389 |
|
| 2013 |
Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care. Neuroscience and Biobehavioral Reviews. 37: 1363-79. PMID 23707776 DOI: 10.1016/J.Neubiorev.2013.05.008 |
0.39 |
|
| 2013 |
Lazzeroni LC, Halbauer JD, Ashford JW, Noda A, Hernandez B, Azor V, Hozack N, Hasson N, Henderson VW, Yesavage JA, Tinklenberg JR. Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008. Journal of Alzheimer's Disease : Jad. 36: 791-8. PMID 23703151 DOI: 10.3233/Jad-130662 |
0.326 |
|
| 2013 |
Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, ... Ashford JW, et al. Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 151-9. PMID 23375564 DOI: 10.1016/J.Jalz.2012.08.008 |
0.373 |
|
| 2013 |
Ashford JW, Bayley PJ. Retrogenesis: a model of dementia progression in Alzheimer's disease related to neuroplasticity. Journal of Alzheimer's Disease : Jad. 33: 1191-3. PMID 23090006 DOI: 10.3233/Jad-2012-121124 |
0.417 |
|
| 2011 |
Johnston JM, Greco SJ, Hamzelou A, Ashford JW, Tezapsidis N. Repositioning leptin as a therapy for Alzheimer's disease. Therapy (London, England : 2004). 8: 481-490. PMID 22121334 DOI: 10.2217/Thy.11.57 |
0.33 |
|
| 2011 |
Ashford JW, Adamson M, Beale T, La D, Hernandez B, Noda A, Rosen A, O'Hara R, Fairchild JK, Spielman D, Yesavage JA. MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia. Journal of Alzheimer's Disease : Jad. 26: 331-6. PMID 21971472 DOI: 10.3233/Jad-2011-0021 |
0.304 |
|
| 2011 |
Ashford JW, Coburn KL, Rose TL, Bayley PJ. P300 energy loss in aging and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 229-38. PMID 21971463 DOI: 10.3233/Jad-2011-0061 |
0.351 |
|
| 2011 |
Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, et al. Imaging the Alzheimer brain. Journal of Alzheimer's Disease : Jad. 26: 1-27. PMID 21971448 DOI: 10.3233/Jad-2011-0073 |
0.396 |
|
| 2011 |
Greco SJ, Hamzelou A, Johnston JM, Smith MA, Ashford JW, Tezapsidis N. Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neurons. Biochemical and Biophysical Research Communications. 414: 170-4. PMID 21945934 DOI: 10.1016/J.Bbrc.2011.09.050 |
0.363 |
|
| 2010 |
Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N, Casadesus G. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 1155-67. PMID 20308782 DOI: 10.3233/Jad-2010-1308 |
0.352 |
|
| 2010 |
Adamson MM, Landy KM, Duong S, Fox-Bosetti S, Ashford JW, Murphy GM, Weiner M, Taylor JL. Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiology of Aging. 31: 1059-63. PMID 18760504 DOI: 10.1016/J.Neurobiolaging.2008.07.017 |
0.371 |
|
| 2009 |
Halbauer JD, Ashford JW, Zeitzer JM, Adamson MM, Lew HL, Yesavage JA. Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. Journal of Rehabilitation Research and Development. 46: 757-96. PMID 20104402 DOI: 10.1682/Jrrd.2008.08.0119 |
0.317 |
|
| 2009 |
Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, Robakis NK, Wolozin B, Perry G, Zhu X, Greco SJ, Sarkar S. Leptin: a novel therapeutic strategy for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 16: 731-40. PMID 19387109 DOI: 10.3233/Jad-2009-1021 |
0.422 |
|
| 2008 |
Greco SJ, Sarkar S, Johnston JM, Zhu X, Su B, Casadesus G, Ashford JW, Smith MA, Tezapsidis N. Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. Biochemical and Biophysical Research Communications. 376: 536-41. PMID 18801339 DOI: 10.1016/J.Bbrc.2008.09.026 |
0.312 |
|
| 2008 |
Ashford JW. Screening for memory disorders, dementia and Alzheimer’s disease Aging Health. 4: 399-432. DOI: 10.2217/1745509X.4.4.399 |
0.382 |
|
| 2007 |
Ashford JW, Kraemer HC, Tinklenberg JR, O'Hara R, Taylor JL, Yesavage JA. Statistical and pharmacoeconomic issues for Alzheimer's screening. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 126; discussion 127-. PMID 19595924 DOI: 10.1016/J.Jalz.2007.03.004 |
0.331 |
|
| 2007 |
Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H, Fillit H. Should older adults be screened for dementia? It is important to screen for evidence of dementia! Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 75-80. PMID 19595920 DOI: 10.1016/J.Jalz.2007.03.005 |
0.348 |
|
| 2006 |
Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H. Should older adults be screened for dementia? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 76-85. PMID 19595860 DOI: 10.1016/J.Jalz.2006.02.005 |
0.339 |
|
| 2005 |
Ashford JW, Atwood CS, Blass JP, Bowen RL, Finch CE, Iqbal K, Joseph JA, Perry G. What is aging? What is its role in Alzheimer's disease? What can we do about it? Journal of Alzheimer's Disease : Jad. 7: 247-53; discussion 2. PMID 16006669 DOI: 10.3233/Jad-2005-7308 |
0.315 |
|
| 2005 |
Ashford JW, Crutcher KA, Robinson SR, Smith MA. Foreword: Challenging views of Alzheimer's disease – 2004 Journal of Alzheimer's Disease. 7: 233-233. DOI: 10.3233/Jad-2005-7305 |
0.347 |
|
| 2004 |
Ashford JW. APOE genotype effects on Alzheimer's disease onset and epidemiology. Journal of Molecular Neuroscience : Mn. 23: 157-65. PMID 15181244 DOI: 10.1385/Jmn:23:3:157 |
0.385 |
|
| 2004 |
Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiology of Aging. 25: 641-50. PMID 15172743 DOI: 10.1016/J.Neurobiolaging.2003.12.023 |
0.363 |
|
| 2003 |
Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA. Designing a Brief Alzheimer Screen (BAS). Journal of Alzheimer's Disease : Jad. 5: 391-8. PMID 14646030 DOI: 10.3233/Jad-2003-5506 |
0.316 |
|
| 2002 |
Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Möbius HJ, Stöffler A. Measuring cognition in advanced Alzheimer's disease for clinical trials. Journal of Neural Transmission. Supplementum. 135-48. PMID 12456059 DOI: 10.1007/978-3-7091-6139-5_14 |
0.316 |
|
| 2000 |
Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology. 55: 370-6. PMID 10932270 DOI: 10.1212/Wnl.55.3.370 |
0.317 |
|
| 1992 |
Freels S, Cohen D, Eisdorfer C, Paveza G, Gorelick P, Luchins DJ, Hirschman R, Ashford JW, Levy P, Semla T. Functional status and clinical findings in patients with Alzheimer's disease. Journal of Gerontology. 47: M177-82. PMID 1430852 DOI: 10.1093/Geronj/47.6.M177 |
0.37 |
|
| Show low-probability matches. |